[HTML][HTML] Combined vitamin C, hydrocortisone, and thiamine therapy for patients with severe pneumonia who were admitted to the intensive care unit: Propensity score …

WY Kim, EJ Jo, JS Eom, J Mok, MH Kim, KU Kim… - Journal of critical …, 2018 - Elsevier
Purpose To evaluate the efficacy of combined vitamin C, hydrocortisone, and thiamine in
patients with severe pneumonia. Materials and methods All consecutive patients with severe …

Effect of Vitamin C on mortality of critically ill patients with severe pneumonia in intensive care unit: a preliminary study

A Mahmoodpoor, K Shadvar, S Sanaie… - BMC infectious …, 2021 - Springer
Background Critically ill patients frequently suffer from vitamin C deficiency. Previous studies
showed that high doses of vitamin C administration had conflicting results on clinical …

Hydrocortisone, vitamin C, and thiamine for the treatment of severe sepsis and septic shock: a retrospective before-after study

PE Marik, V Khangoora, R Rivera, MH Hooper… - Chest, 2017 - Elsevier
Background The global burden of sepsis is estimated as 15 to 19 million cases annually,
with a mortality rate approaching 60% in low-income countries. Methods In this retrospective …

Vitamin C and thiamine for sepsis and septic shock

AB Mitchell, TE Ryan, AR Gillion, LD Wells… - The American Journal of …, 2020 - Elsevier
Background Sepsis and septic shock are medical emergencies resulting in significant
morbidity and mortality. Intravenous (IV) vitamin C, thiamine, and hydrocortisone have …

Vitamin C, hydrocortisone, and thiamine for the treatment of severe sepsis and septic shock: a retrospective analysis of real-world application

JJ Litwak, N Cho, HB Nguyen, K Moussavi… - Journal of clinical …, 2019 - mdpi.com
A recent study suggested mortality benefits using vitamin C, hydrocortisone, and thiamine
combination therapy (triple therapy) in addition to standard care in patients with severe …

Evaluating vitamin C in septic shock: a randomized controlled trial of vitamin C monotherapy

DA Wacker, SL Burton, JP Berger, AJ Hegg… - Critical care …, 2022 - journals.lww.com
OBJECTIVES: To determine whether IV vitamin C therapy reduces 28-day mortality in
patients with septic shock. DESIGN: Multicenter, double-blinded, randomized controlled trial …

Effect of vitamin C, thiamine, and hydrocortisone on ventilator-and vasopressor-free days in patients with sepsis: the VICTAS randomized clinical trial

JE Sevransky, RE Rothman, DN Hager, GR Bernard… - Jama, 2021 - jamanetwork.com
Importance Sepsis is a common syndrome with substantial morbidity and mortality. A
combination of vitamin C, thiamine, and corticosteroids has been proposed as a potential …

The Vitamin C, Thiamine and Steroids in Sepsis (VICTAS) Protocol: a prospective, multi-center, double-blind, adaptive sample size, randomized, placebo-controlled …

DN Hager, MH Hooper, GR Bernard, LW Busse… - Trials, 2019 - Springer
Background Sepsis accounts for 30% to 50% of all in-hospital deaths in the United States.
Other than antibiotics and source control, management strategies are largely supportive with …

Use of hydrocortisone, ascorbic acid, and thiamine in adults with septic shock

EA Vail, H Wunsch, R Pinto, NA Bosch… - American journal of …, 2020 - atsjournals.org
Rationale: In December 2016, a single-center study describing significant improvements in
mortality among a small group of patients with severe sepsis and septic shock treated with …

[HTML][HTML] Vitamin C therapy for routine care in septic shock (ViCTOR) trial: effect of intravenous vitamin C, thiamine, and hydrocortisone administration on inpatient …

ZU Mohamed, P Prasannan, M Moni… - Indian journal of …, 2020 - ncbi.nlm.nih.gov
Background Sepsis remains a leading cause of death worldwide despite advances in
management strategies. Preclinical and observational studies have found mortality benefit …